Cystatin-C as a Marker for Renal Impairment in Preeclampsia

Table 1

Baseline and clinical parameters of study participants.

General characteristics	PE	Control	value
Age (years)	26.84 ± 5.20	25.84 ± 4.54
POG (weeks)	35.02 ± 4.59	29.35 ± 3.35
BMI (Kg/m^2)	28.71 ± 4.30	24.47 ± 2.86
SBP (mmHg)	146.86 ± 10.67	104.31 ± 10.24
DBP (mmHg)	95.69 ± 8.77	71.76 ± 7.67
MAP	112.74 ± 8.21	8.21 ± 7.86

-test; value < 0.05 is considered to be significant.